EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advances in treatment strategies for low-grade serous ovarian cancer

Lucia Musacchio, Domenica Lorusso, Giulia Sabetta, Alessandra Giustozzi, Elena Giudice, Maria Chiara Cannizzaro, Maria Teresa Perri, Anna Fagotti, Vanda Salutari

Cancer Treatment Reviews · 2025

DOI: 10.1016/j.ctrv.2025.103019 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2025. Verfasst von Lucia Musacchio und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gynecologic Oncology Unit, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome …. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Cystadenocarcinoma, Serous. Die Arbeit nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Low-grade serous ovarian carcinoma (LGSOC) represents a unique therapeutic challenge in gynecologic oncology. While it accounts for a minority of epithelial ovarian cancers (EOC), its distinct molecular landscape and limited sensitivity to conventional chemotherapy underscore the urgent need for alternative treatment paradigms. Over the past decade, advances in genomic profiling have led to a deeper understanding of its biology, revealing recurrent alterations in key signaling pathways such as (mitogen-activated protein kinase) MAPK, PI3K, and cell cycle regulators. These insights have catalyzed a shift toward precision medicine, with targeted agents and endocrine strategies emerging as promising avenues. However, despite encouraging signals from clinical trials, the rarity of LGSOC continues to hinder the development of robust, evidence-based standards. In this review, we critically examine the current treatment landscape and explore evolving therapeutic strategies, including ongoing efforts to integrate molecular biomarkers into clinical decision-making. By synthesizing recent evidence and highlighting key areas of unmet need, this review aims to provide a forward-looking perspective on the treatment of LGSOC. Future progress will depend on collaborative research, biomarker-driven clinical trial design, and a commitment to tailoring therapy based on the unique biology of this rare tumor type.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsCystadenocarcinoma, SerousHumansFemaleMolecular Targeted TherapyNeoplasm GradingCarcinoma, Ovarian Epithelial

Stichwörter der Autor:innen

Antibody-drug conjugatesChemotherapyHormonal therapyImmunotherapyLow grade serous ovarian carcinomaTargeted-therapy

Autor:innen und Institutionen

  • Gynecologic Oncology Unit, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome 00168, Italy.
  • Faculty of Medicine and Surgery, Humanitas University, Milan, Italy; Operative Unit of Gynecologic Oncology, Humanitas San Pio X, Via Francesco Nava, 31, Milan 20159, Italy. Electronic address: domenica.lorusso@hunimed.…
  • Institute of Obstetrics and Gynecology, Università Cattolica del Sacro Cuore, Largo Agostino Gemelli 8, Rome 00168, Italy.
  • Operative Unit of Gynecologic Oncology, Humanitas San Pio X, Via Francesco Nava, 31, Milan 20159, Italy.
  • Gynecologic Oncology Unit, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome 00168, Italy; Institute of Obstetrics and Gynecology, Università Catto…

Zitieren

APA

Musacchio, L., Lorusso, D., Sabetta, G., Giustozzi, A., Giudice, E., Cannizzaro, M. C., Perri, M. T., Fagotti, A., & Salutari, V. (2025). Advances in treatment strategies for low-grade serous ovarian cancer. Cancer Treatment Reviews. https://doi.org/10.1016/j.ctrv.2025.103019

Vancouver

Musacchio L, Lorusso D, Sabetta G, Giustozzi A, Giudice E, Cannizzaro MC, et al. Advances in treatment strategies for low-grade serous ovarian cancer. Cancer Treatment Reviews. 2025. doi:10.1016/j.ctrv.2025.103019

BibTeX
@article{Musacchio2025,
  author = {Musacchio, Lucia and Lorusso, Domenica and Sabetta, Giulia and Giustozzi, Alessandra and Giudice, Elena and Cannizzaro, Maria Chiara and Perri, Maria Teresa and Fagotti, Anna and Salutari, Vanda},
  title = {Advances in treatment strategies for low-grade serous ovarian cancer},
  journal = {Cancer Treatment Reviews},
  year = {2025},
  doi = {10.1016/j.ctrv.2025.103019}
}
Kostenlos starten →